Eps15 Activators

The chemical class of 'Eps15 Activators' largely consists of compounds that indirectly influence the function of Eps15 through modulation of endocytosis and signaling pathways, particularly those associated with the epidermal growth factor receptor (EGFR). Eps15 plays a role in the internalization of EGFR and is involved in clathrin-mediated endocytosis, a key cellular process for the internalization of various receptors and molecules. Compounds like EGF, and Gefitinib affect Eps15 indirectly by modulating EGFR signaling. EGF stimulates EGFR, which is a primary pathway involving Eps15, whereas Gefitinib inhibits EGFR kinase activity, potentially influencing Eps15's role in EGFR endocytosis.

Chlorpromazine inhibit clathrin-mediated endocytosis, potentially affecting Eps15 function. SU11274, as a Met receptor tyrosine kinase inhibitor, and Genistein, as a broad-spectrum tyrosine kinase inhibitor, can affect various signaling pathways, potentially including those in which Eps15 is involved. Wortmannin, a PI3K inhibitor, may affect Eps15 by altering signaling pathways and endocytic processes that involve PI3K. U73122 inhibits phospholipase C, an enzyme involved in intracellular signaling, which could indirectly influence Eps15 function. Finally, Curcumin, known for its broad effects on various signaling pathways, may also have an indirect impact on Eps15 activity.